NORTH AMERICA BIOPHARMA Trademark

Trademark Overview

On Tuesday, December 10, 2024, a trademark application was filed for NORTH AMERICA BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the NORTH AMERICA BIOPHARMA trademark a serial number of 98894336. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 23, 2025. This trademark is owned by North America BioPharma. The NORTH AMERICA BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Leeches for medical purposes
north america biopharma

General Information

Serial Number98894336
Word MarkNORTH AMERICA BIOPHARMA
Filing DateTuesday, December 10, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2025

Trademark Statements

Goods and ServicesLeeches for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2024
Primary Code005
First Use Anywhere DateTuesday, November 24, 2015
First Use In Commerce DateFriday, November 27, 2015

Trademark Owner History

Party NameNorth America BioPharma
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressERIE, CO 80516
Party NameNorth America BioPharma
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressERIE, CO 80516

Trademark Events

Event DateEvent Description
Tuesday, December 10, 2024NEW APPLICATION ENTERED
Tuesday, December 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 28, 2025ASSIGNED TO EXAMINER
Tuesday, June 10, 2025NON-FINAL ACTION WRITTEN
Tuesday, June 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 10, 2025NON-FINAL ACTION E-MAILED
Friday, July 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, August 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 17, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 23, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 23, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, August 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

biopharma america north purposes medical leeches